10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0000874716-20-000031`
Period End Date	20200630
Filing Date	20200731
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	idxx-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 74 Cash Flow Statement 68 Stockholders Equity 48 Comprehensive Income 72

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$90.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$105.29M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	105.71M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	106.03M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$269.31M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$320.32M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	85.47M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	85.05M	shares	Point-in-time
Inventories	`InventoryNet`	$229.38M	USD	Point-in-time
Deferred stock units, outstanding (in shares)	`CommonStockOtherSharesOutstanding`	143,000.00	shares	Point-in-time
Inventories	`InventoryNet`	$195.02M	USD	Point-in-time
Deferred stock units, outstanding (in shares)	`CommonStockOtherSharesOutstanding`	147,000.00	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	20.98M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	20.24M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$124.98M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$124.62M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$679.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$779.61M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$533.85M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$550.89M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$80.61M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$82.41M	USD	Point-in-time
Goodwill	`Goodwill`	$239.72M	USD	Point-in-time
Goodwill	`Goodwill`	$235.43M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$58.47M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.62M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$256.75M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$240.19M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$1.18B	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$1.15B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.96B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.83B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$73.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$72.17M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$308.77M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$322.94M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$288.76M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$121.60M	USD	Point-in-time
Current portion of deferred revenue	`ContractWithCustomerLiabilityCurrent`	$36.32M	USD	Point-in-time
Current portion of deferred revenue	`ContractWithCustomerLiabilityCurrent`	$41.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$540.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$725.34M	USD	Point-in-time
Deferred income tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$36.60M	USD	Point-in-time
Deferred income tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$33.02M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$899.56M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$698.91M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$48.74M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$57.76M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$68.60M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$67.47M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$81.16M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$84.21M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.15B	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$929.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.65B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.69B	USD	Point-in-time
Commitments and Contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 106,031 shares in 2020 and 105,711 shares in 2019; Outstanding: 85,049 shares in 2020 and 85,471 shares in 2019	`CommonStockValue`	$10.60M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 106,031 shares in 2020 and 105,711 shares in 2019; Outstanding: 85,049 shares in 2020 and 85,471 shares in 2019	`CommonStockValue`	$10.57M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.25B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.21B	USD	Point-in-time
Deferred stock units: Outstanding: 147 units in 2020 and 143 units in 2019	`CommonStockOtherValueOutstanding`	$5.40M	USD	Point-in-time
Deferred stock units: Outstanding: 147 units in 2020 and 143 units in 2019	`CommonStockOtherValueOutstanding`	$4.46M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.60B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.85B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-46.18M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-57.03M	USD	Point-in-time
Treasury stock, at cost: 20,981 shares in 2020 and 20,240 shares in 2019	`TreasuryStockValue`	$2.60B	USD	Point-in-time
Treasury stock, at cost: 20,981 shares in 2020 and 20,240 shares in 2019	`TreasuryStockValue`	$2.79B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity	`StockholdersEquity`	$177.47M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity	`StockholdersEquity`	$272.96M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$437.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$352.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$177.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$51.87M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$273.40M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$108.06M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$1.96B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$1.83B	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$620.10M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$637.59M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.26B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.20B	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$258.25M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$262.25M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$525.00M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$506.71M	USD	2 Qtrs
Gross profit	`GrossProfit`	$689.45M	USD	2 Qtrs
Gross profit	`GrossProfit`	$738.93M	USD	2 Qtrs
Gross profit	`GrossProfit`	$357.85M	USD	1 Quarter
Gross profit	`GrossProfit`	$379.34M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$210.32M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$101.36M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$207.95M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$94.18M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$126.08M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$59.95M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$120.32M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$60.27M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$63.77M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$32.26M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$31.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$64.95M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$337.57M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$193.25M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$164.28M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$297.41M	USD	2 Qtrs
Interest expense	`InterestExpense`	$8.19M	USD	1 Quarter
Interest expense	`InterestExpense`	$9.49M	USD	1 Quarter
Interest expense	`InterestExpense`	$16.57M	USD	2 Qtrs
Interest expense	`InterestExpense`	$17.19M	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$209.00K	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$69.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$73.00K	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$33.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$183.82M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$156.12M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$280.91M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$320.60M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$34.83M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$52.50M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$30.42M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$59.74M	USD	2 Qtrs
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Net income	`ProfitLoss`	$260.85M	USD	2 Qtrs
Net income	`ProfitLoss`	$149.00M	USD	1 Quarter
Net income	`ProfitLoss`	$228.41M	USD	2 Qtrs
Net income	`ProfitLoss`	$125.70M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00K	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$56.00K	USD	1 Quarter
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$85.00K	USD	2 Qtrs
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.00K	USD	2 Qtrs
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$148.94M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$228.39M	USD	2 Qtrs
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$260.77M	USD	2 Qtrs
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$125.71M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.46	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.65	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.06	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.75	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.61	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.72	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.43	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.01	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	85.13M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	86.22M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	86.21M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	85.28M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.59M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	86.57M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.61M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	86.40M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Net income	`ProfitLoss`	$260.85M	USD	2 Qtrs
Net income	`ProfitLoss`	$149.00M	USD	1 Quarter
Net income	`ProfitLoss`	$228.41M	USD	2 Qtrs
Net income	`ProfitLoss`	$125.70M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$46.79M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$42.98M	USD	2 Qtrs
Provision for credit losses (Note 2 & Note 6)	`ProvisionForLoanLeaseAndOtherLosses`	$299.00K	USD	2 Qtrs
Provision for credit losses (Note 2 & Note 6)	`ProvisionForLoanLeaseAndOtherLosses`	$5.35M	USD	2 Qtrs
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$2.66M	USD	2 Qtrs
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.43M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$13.23M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$15.08M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$699.00K	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$448.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$37.70M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$57.28M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$22.91M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$29.25M	USD	2 Qtrs
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-4.54M	USD	2 Qtrs
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$45.82M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-4.03M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-6.73M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-6.85M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-6.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$171.48M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$236.01M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$73.56M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$71.99M	USD	2 Qtrs
Payments to Acquire Intangible Assets	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Payments to Acquire Intangible Assets	`PaymentsToAcquireIntangibleAssets`	$668.00K	USD	2 Qtrs
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$304.00K	USD	2 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-74.23M	USD	2 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-72.29M	USD	2 Qtrs
Repayments on revolving credit facilities, net	`RepaymentsOfLongTermLinesOfCredit`	$167.69M	USD	2 Qtrs
Repayments on revolving credit facilities, net	`RepaymentsOfLongTermLinesOfCredit`	$147.52M	USD	2 Qtrs
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$200.00M	USD	2 Qtrs
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$100.00M	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$142.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$4.99M	USD	2 Qtrs
Payment of acquisition-related contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$1.70M	USD	2 Qtrs
Payment of acquisition-related contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$1.08M	USD	2 Qtrs
Repurchases of common stock, net	`PaymentsForRepurchaseOfCommonStock`	$74.99M	USD	2 Qtrs
Repurchases of common stock, net	`PaymentsForRepurchaseOfCommonStock`	$182.81M	USD	2 Qtrs
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$20.61M	USD	2 Qtrs
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$19.65M	USD	2 Qtrs
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.67M	USD	2 Qtrs
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$7.57M	USD	2 Qtrs
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-112.27M	USD	2 Qtrs
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-144.63M	USD	2 Qtrs
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.19M	USD	2 Qtrs
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$131.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-12.95M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.97M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$105.29M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.33M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.84M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$123.79M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$105.29M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.33M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$110.84M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$123.79M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$56.95M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$29.98M	USD	2 Qtrs
Unpaid property and equipment, reflected in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$11.63M	USD	2 Qtrs
Unpaid property and equipment, reflected in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$12.67M	USD	2 Qtrs

Stockholders Equity 48 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Balance beginning of period (in shares)	`CommonStockSharesIssued`	105.71M	shares	Point-in-time
Balance beginning of period (in shares)	`CommonStockSharesIssued`	106.03M	shares	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$177.82M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$51.87M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$273.40M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.55M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$108.06M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$102.71M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$260.85M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$149.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$228.41M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$125.70M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$111.86M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$1.21M	USD	2 Qtrs
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-1.79M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-10.85M	USD	2 Qtrs
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-9.06M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-568.00K	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$1.78M	USD	1 Quarter
Repurchases of common stock, net	`TreasuryStockValueAcquiredCostMethod`	$20.34M	USD	1 Quarter
Repurchases of common stock, net	`TreasuryStockValueAcquiredCostMethod`	$61.13M	USD	1 Quarter
Repurchases of common stock, net	`TreasuryStockValueAcquiredCostMethod`	$187.77M	USD	1 Quarter
Issuances of common stock, net	`StockIssuedDuringPeriodValueNewIssues`	$258.00K	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$9.75M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$7.99M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$11.42M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$10.08M	USD	1 Quarter
Deferred stock units activity	`IssuanceVestingAndSettlementOfDeferredStockUnits`	-	USD	1 Quarter
Deferred stock units activity	`IssuanceVestingAndSettlementOfDeferredStockUnits`	-	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.80M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.90M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.28M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.33M	USD	1 Quarter
Balance end of period (in shares)	`CommonStockSharesIssued`	105.71M	shares	Point-in-time
Balance end of period (in shares)	`CommonStockSharesIssued`	106.03M	shares	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$177.82M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$51.87M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$273.40M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.55M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$108.06M	USD	Point-in-time

Comprehensive Income 72 line items

Line Item	Tag	Value	Unit	Period
Unrealized (loss) gain on Euro-denominated notes, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax`	$-532.00K	USD	1 Quarter
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Unrealized (loss) gain on Euro-denominated notes, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax`	$-309.00K	USD	1 Quarter
Unrealized (loss) gain on Euro-denominated notes, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax`	$-202.00K	USD	2 Qtrs
Net income	`ProfitLoss`	$260.85M	USD	2 Qtrs
Net income	`ProfitLoss`	$149.00M	USD	1 Quarter
Net income	`ProfitLoss`	$228.41M	USD	2 Qtrs
Unrealized (loss) gain on Euro-denominated notes, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax`	$158.00K	USD	2 Qtrs
Net income	`ProfitLoss`	$125.70M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-181.00K	USD	2 Qtrs
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-93.00K	USD	1 Quarter
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-14.00K	USD	1 Quarter
Unrealized (loss) gain on investments, tax (benefit) expense	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$114.00K	USD	2 Qtrs
Unrealized gain (loss) on foreign currency exchange contracts, tax (benefit) expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$-21.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-15.20M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$7.01M	USD	1 Quarter
Unrealized gain (loss) on foreign currency exchange contracts, tax (benefit) expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$203.00K	USD	2 Qtrs
Unrealized gain (loss) on foreign currency exchange contracts, tax (benefit) expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$1.25M	USD	2 Qtrs
Unrealized gain (loss) on foreign currency exchange contracts, tax (benefit) expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$-805.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.68M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.10M	USD	1 Quarter
Unrealized (loss) gain on Euro-denominated notes, net of tax (benefit) expense of $(532) and $(202) in 2020 and $(309) and $158 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax`	$500.00K	USD	2 Qtrs
Unrealized (loss) gain on Euro-denominated notes, net of tax (benefit) expense of $(532) and $(202) in 2020 and $(309) and $158 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax`	$-642.00K	USD	2 Qtrs
Unrealized gain (loss) on cross currency swaps, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax`	$-283.00K	USD	1 Quarter
Unrealized gain (loss) on cross currency swaps, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax`	$159.00K	USD	2 Qtrs
Unrealized (loss) gain on Euro-denominated notes, net of tax (benefit) expense of $(532) and $(202) in 2020 and $(309) and $158 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax`	$-1.69M	USD	1 Quarter
Unrealized gain (loss) on cross currency swaps, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax`	$-148.00K	USD	1 Quarter
Unrealized (loss) gain on Euro-denominated notes, net of tax (benefit) expense of $(532) and $(202) in 2020 and $(309) and $158 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax`	$-980.00K	USD	1 Quarter
Unrealized gain (loss) on cross currency swaps, tax (benefit) expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax`	$586.00K	USD	2 Qtrs
Unrealized (loss) gain on investments, net of tax (benefit) expense of $(93) and $(181) in 2020 and $(14) and $114 in 2019	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-574.00K	USD	2 Qtrs
Reclassification adjustment for (gain) loss included in net income, tax expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$358.00K	USD	1 Quarter
Reclassification adjustment for (gain) loss included in net income, tax expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$339.00K	USD	1 Quarter
Reclassification adjustment for (gain) loss included in net income, tax expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$607.00K	USD	2 Qtrs
Unrealized (loss) gain on investments, net of tax (benefit) expense of $(93) and $(181) in 2020 and $(14) and $114 in 2019	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-295.00K	USD	1 Quarter
Unrealized (loss) gain on investments, net of tax (benefit) expense of $(93) and $(181) in 2020 and $(14) and $114 in 2019	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-45.00K	USD	1 Quarter
Reclassification adjustment for (gain) loss included in net income, tax expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$579.00K	USD	2 Qtrs
Unrealized (loss) gain on investments, net of tax (benefit) expense of $(93) and $(181) in 2020 and $(14) and $114 in 2019	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$362.00K	USD	2 Qtrs
Unrealized gain (loss) on foreign currency exchange contracts, net of tax (benefit) expense of $(805) and $1,247 in 2020 and $(21) and $203 in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$67.00K	USD	1 Quarter
Unrealized gain (loss) on foreign currency exchange contracts, net of tax (benefit) expense of $(805) and $1,247 in 2020 and $(21) and $203 in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$-3.89M	USD	1 Quarter
Unrealized gain (loss) on foreign currency exchange contracts, net of tax (benefit) expense of $(805) and $1,247 in 2020 and $(21) and $203 in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$5.54M	USD	2 Qtrs
Unrealized gain (loss) on foreign currency exchange contracts, net of tax (benefit) expense of $(805) and $1,247 in 2020 and $(21) and $203 in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$1.11M	USD	2 Qtrs
Unrealized gain (loss) on cross currency swaps, net of tax expense (benefit) expense of $(283) and $586 in 2020 and $(148) and $159 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax`	$-1.45M	USD	1 Quarter
Unrealized gain (loss) on cross currency swaps, net of tax expense (benefit) expense of $(283) and $586 in 2020 and $(148) and $159 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax`	$-563.00K	USD	1 Quarter
Unrealized gain (loss) on cross currency swaps, net of tax expense (benefit) expense of $(283) and $586 in 2020 and $(148) and $159 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax`	$2.60M	USD	2 Qtrs
Unrealized gain (loss) on cross currency swaps, net of tax expense (benefit) expense of $(283) and $586 in 2020 and $(148) and $159 in 2019	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax`	$868.00K	USD	2 Qtrs
Reclassification adjustment for (gain) included in net income, net of tax (expense) of $(339) and $(579) in 2020 and $(358) and $(607) in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$1.47M	USD	1 Quarter
Reclassification adjustment for (gain) included in net income, net of tax (expense) of $(339) and $(579) in 2020 and $(358) and $(607) in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$2.57M	USD	2 Qtrs
Reclassification adjustment for (gain) included in net income, net of tax (expense) of $(339) and $(579) in 2020 and $(358) and $(607) in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$2.15M	USD	1 Quarter
Reclassification adjustment for (gain) included in net income, net of tax (expense) of $(339) and $(579) in 2020 and $(358) and $(607) in 2019	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$3.31M	USD	2 Qtrs
Unrealized (loss) gain on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax`	$-6.81M	USD	1 Quarter
Unrealized (loss) gain on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax`	$-1.33M	USD	2 Qtrs
Unrealized (loss) gain on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax`	$-2.65M	USD	1 Quarter
Unrealized (loss) gain on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax`	$5.57M	USD	2 Qtrs
Other comprehensive (loss) gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$1.21M	USD	2 Qtrs
Other comprehensive (loss) gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-1.79M	USD	1 Quarter
Other comprehensive (loss) gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-10.85M	USD	2 Qtrs
Other comprehensive (loss) gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.06M	USD	1 Quarter
Other comprehensive (loss) gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-568.00K	USD	1 Quarter
Other comprehensive (loss) gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$1.78M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$250.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$125.13M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$229.62M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$147.21M	USD	1 Quarter
Less: Comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-5.00K	USD	1 Quarter
Less: Comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$56.00K	USD	1 Quarter
Less: Comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$85.00K	USD	2 Qtrs
Less: Comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$23.00K	USD	2 Qtrs
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$125.14M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$249.92M	USD	2 Qtrs
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$147.15M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$229.59M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.